PIPK I α activators belong to a specific chemical class of compounds or molecules that play a pivotal role in intracellular signaling and membrane dynamics. PIPK I α, also known as phosphatidylinositol 4-phosphate 5-kinase type I alpha, is an enzyme responsible for the phosphorylation of phosphatidylinositol 4-phosphate (PI4P) to generate phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) in cell membranes. This conversion is a crucial step in the regulation of various cellular processes, as PI(4,5)P2 serves as a precursor for the generation of secondary messengers and plays a key role in membrane trafficking, cytoskeletal dynamics, and cell signaling.
The role of PIPK I α activators is to modulate the activity of PIPK I α, thereby influencing the levels of PI(4,5)P2 in the cell. By activating PIPK I α, these molecules enhance the production of PI(4,5)P2, which, in turn, impacts downstream signaling pathways and cellular functions. PI(4,5)P2 is involved in the recruitment and activation of various effector proteins, such as ion channels, kinases, and scaffolding proteins, at the cell membrane. This activation, in turn, regulates processes like membrane fusion, vesicle trafficking, and actin cytoskeleton dynamics.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. Elevated calcium can modulate various signaling pathways, potentially influencing PIPK I α activity. | ||||||
GSK 650394 | 890842-28-1 | sc-361201 sc-361201A | 10 mg 50 mg | $187.00 $769.00 | 8 | |
GSK650394 is an inhibitor of SGK1, a serine/threonine kinase. SGK1 inhibition can affect signaling pathways that may indirectly modulate PIPK I α activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor that affects the MAPK/ERK pathway. This pathway intersects with phosphoinositide signaling, potentially impacting PIPK I α activity. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein, a tyrosine kinase inhibitor, can affect various signaling pathways. Its broad action might indirectly influence PIPK I α activity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum kinase inhibitor. Its wide range of targets includes kinases that could indirectly modulate PIPK I α activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor. mTOR signaling has connections to lipid signaling pathways, potentially influencing PIPK I α activity. | ||||||
NF 449 | 389142-38-5 | sc-203159 | 10 mg | $314.00 | 5 | |
NF449 is a potent Gs-alpha subunit inhibitor, which could impact cAMP levels and related signaling pathways, indirectly affecting PIPK I α activity. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine, known to influence cAMP phosphodiesterase, may alter signaling pathways that indirectly impact PIPK I α activity. | ||||||